AZTA (Azenta) Notes Receivable: $0.0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

AZTA Azenta Inc AZTA
78 GF Score
Price $32.96
GF Value $52.25
Valuation Significantly Undervalued
! 1 Warning Sign
View Full Analysis

What is Azenta Notes Receivable?

Azenta AZTA -1.95% 78 Notes Receivable is $0.0 Mil as of Jun. 2026. GuruFocus rates AZTA with a GF Score™ of 78/100 and a GF Value™ of $52.25 (Significantly Undervalued). The stock has 1 warning sign investors should review.

Azenta's Notes Receivable for the quarter that ended in Jun. 2026 was $0.0 Mil.

Azenta Notes Receivable Historical Data

* Premium members only.

The historical data trend for Azenta's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Azenta Notes Receivable Chart

Azenta Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Notes Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Azenta Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
AZTA
78GF Score
Azenta Inc AZTA
Notes Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Azenta Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of $0.0 Mil mean?
Azenta (AZTA) has a Notes Receivable of $0.0 Mil as of Jun. 2026. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Azenta and its competitors.
Is Azenta's Notes Receivable too high?
Azenta's current Notes Receivable is $0.0 Mil. Overall, Azenta has a GF Score™ of 78/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Azenta's Notes Receivable compare to KMTS and STAA?
Azenta's Notes Receivable of $0.0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Medical Devices & Instruments company?
A good Notes Receivable depends on the Medical Devices & Instruments industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Azenta and its competitors. Azenta's current Notes Receivable is $0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Azenta stock overvalued right now?
Based on GuruFocus' analysis, Azenta (AZTA) is currently considered Significantly Undervalued. The stock's GF Value™ is $52.25, compared to a current price of $32.96 — trading 36.9% below its estimated fair value. The current Notes Receivable is $0.0 Mil. Azenta's overall GF Score™ is 78/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For Azenta (AZTA), the current Notes Receivable is $0.0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Azenta (AZTA) Overvalued in 2026?

Based on GuruFocus' analysis, Azenta stock appears to be undervalued. The current stock price of $32.96 is trading 36.9% below its estimated GF Value™ of $52.25. GuruFocus considers Azenta to be Significantly Undervalued.

Key valuation signals for AZTA:

  • Notes Receivable: $0.0 Mil
  • GF Value™: $52.25 vs. price of $32.96 (36.9% below fair value)
  • GF Score™: 78/100 with 1 warning sign

No single metric tells the full story. See the AZTA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Azenta Business Description

Other Exchanges 0HQ1:UKBA3:Germany
Address 200 Summit Drive, 6th Floor, Burlington, MA, USA, 01803
Azenta Inc provides biological and chemical sample exploration and management solutions, using precision automation and cryogenics to develop automated ultra-cold storage. It serves customers from research to commercialization with sample management, automated storage, genomic services, consumables, informatics, and repository services. The company operates through two segments: Sample Management Solutions, offering SRS and Core Products such as automated stores, cryogenic systems, sample tubes, consumables, instruments, and thawing devices, which generate majority of its revenue; and Multiomics, which provides genomic analysis services. The company operates in United States, China, United Kingdom, rest of Europe, and others, with majority of its revenue in the United States.
78GF Score

Get the complete analysis for AZTA

Notes Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$32.96
Price
$52.25
GF Value